Weld Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Weld Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,512	Closed	-$353K	–	724
2020 Q3	$353K	Buy	+8,512	New	+$391K	0.14%	252
2020 Q1	–	Sell	-2,442	Closed	-$303K	–	775
2019 Q4	$303K	Sell	2,442 -13,644	-85%	-$1.22M	0.06%	469
2019 Q3	$1.07M	Buy	+16,086	New	+$1.08M	0.2%	151
2019 Q1	–	Sell	-5,242	Closed	-$528K	–	932
2018 Q4	$528K	Buy	+5,242	New	+$543K	0.12%	328

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Weld Capital Management's ICPT Position: Q4 2020 in Review

Weld Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 8,512 shares — an estimated $353K sold.

Weld Capital Management first reported a position in ICPT in Q4 2018 and held it in 4 quarters. The position peaked at $1.07M in Q3 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

Weld Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Weld Capital Management sold 8,512 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $353K.
Weld Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
Weld Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $1.07M in Q3 2019.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.